Latest News and Press Releases

MARTINSRIED and MUNICH, Germany, Nov. 5, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX, OTC: MPSYY) today announced upcoming presentations of data on the Company's...

MARTINSRIED and MUNICH, Germany, Nov. 4, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX, OTC: MPSYY) today announced its financial results for the nine months ending...

MARTINSRIED / MUNICH, Germany, Oct. 30, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that it has received a milestone payment from Bayer...

MARTINSRIED / MUNICH, Germany, Oct. 28, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first nine months' 2015 results on November 4, 2015 at 7:00 am...

MARTINSRIED / MUNICH, Germany, Sept. 23, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today published updated safety and preliminary efficacy data on...

Lead Cancer Program MOR208 to be Examined in Numerous Combination Studies in Hematological Cancers Conference call and webcast (in English) today at 2:00pm CEST (1:00pm BST/8:00am...

MARTINSRIED / MUNICH, Germany, Sept. 4, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following conferences: Commerzbank Sector...

MARTINSRIED, Germany, Aug. 25, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and Immatics Biotechnologies GmbH announced today a strategic alliance to...

MARTINSRIED / MUNICH, Germany, Aug. 4, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and G7 Therapeutics AG announced today that they have signed an...

MARTINSRIED / MUNICH, Germany, July 30, 2015 (GLOBE NEWSWIRE) -- Successful Discovery Alliance Combines Two Leading Technologies MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY)...